Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 7, 2015, Pages 1606-1613

  Barry, Simone E ^a,b,c   Chan, Brian ^a   Ellis, Magda ^a,b   Yang, Yurong ^d,e   Plit, Marshall L ^c   Guan, Guangyu ^f   Wang, Xiaolin ^g   Britton, Warwick J ^a,b   Saunders, Bernadette M ^a,b  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d NINGXIA MEDICAL UNIVERSITY   (China)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f Center of Disease Control and Prevention of Ningxia Autonomous Region   (China)

^g Infectious Disease Hospital of Ningxia   (China)

Author keywords

MicroRNA; Normalisation; Plasma; Respiratory disease; Tuberculosis

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 16; MICRORNA 191; MICRORNA 192; MICRORNA 22; MICRORNA 221; MICRORNA 26; MICRORNA 425; MICRORNA 93; UNCLASSIFIED DRUG; MIRN93 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNU6B GENE; TUBERCULOSIS; ADOLESCENT; AUSTRALIA; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETICS; MIDDLE AGED; SOFTWARE; STANDARD; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REFERENCE STANDARDS; SOFTWARE; TUBERCULOSIS; YOUNG ADULT;

EID: 84933057049     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12535     Document Type: Article

References (39)

1. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011; 378: 57-72.
2. World Health Organization. Global tuberculosis control 2011. WHO Rep. 2011. Available at http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf.
3. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Eng J Med. 2010; 363: 1005-15.
4. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010; 107: 1047-57.
5. Mastronardi ML, Mostefai HA, Meziani F, et al. Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Med Mal Infect. 2012; 39: 1739-48.
6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5: 522-31.
7. Oak SR, Murray L, Herath A, et al. A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS ONE. 2011; 6: e21253.
8. Benz F, Roderburg C, Vargas Cardenas D, et al. U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med. 2013; 45: e42.
9. Ng EKO, Chong WWS, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009; 58: 1375-81.
10. Ji F, Yang B, Peng X, et al. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat. 2011; 18: e242-51.
11. Liu JJ, Yao HY, Liu EY. Analysis of factors affecting the epidemiology of tuberculosis in China. Int J Tuberc Lung Dis. 2005; 9: 450-4.
12. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3: research0034.1.
13. Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64: 5245-50.
14. Larson MG. Analysis of variance. Circulation. 2008; 117: 115-21.
15. Boon RA, Vickers KC. Intercellular transport of MicroRNAs. Vasc Biol. 2013; 33: 186-92.
16. Diehl P, Fricke A, Sander L, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res. 2012; 93: 633-44.
17. Marcucci G, Maharry KS, Metzeler KH, et al. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol. 2013; 31: 2086-93.
18. Sanchez-Espiridion B, Martin-Moreno AM, Montalban C, et al. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma. Br J Haematol. 2013; 162: 336-47.
19. Sozzi G, Boeri M, Rossi M, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol. 2014; 32: 768-73.
20. Suryawanshi S, Vlad AM, Lin HM, et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res. 2013; 19: 1213-24.
21. Liang Y, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genom. 2007; 8: 166.
22. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18: 997-1006.
23. Appaiah HN, Goswami CP, Mina LA, et al. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res. 2011; 13: R86.
24. Akbas F, Coskunpinar E, Aynaci E, et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res. 2012; 38: 286-94.
25. Chang KH, Mestdagh P, Vandesompele J, et al. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer. 2010; 10: 173.
26. Chen X, Liang H, Guan D, et al. A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs. PLoS ONE. 2013; 8: e79652.
27. Davoren PA, McNeill RE, Lowery AJ, et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 2008; 9: 76.
28. Liu Z, Zhou G, Deng X, et al. Analysis of miRNA expression profiling in human macrophages responding to Mycobacterium infection: induction of the immune regulator miR-146a. J Infect. 2014; 68: 553-61.
29. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008; 14: 844-52.
30. Song J, Bai Z, Han W, et al. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci. 2012; 57: 897-904.
31. Zheng G, Wang H, Zhang X, et al. Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS ONE. 2013; 8: e83025.
32. Zhu HT, Dong QZ, Wang G, et al. Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol. 2012; 50: 49-56.
33. Yamada H, Itoh M, Hiratsuka I, et al. Circulating microRNAs in autoimmune thyroid diseases. Clin Endocrinol. 2014; 81: 276-81.
34. Wu SC, Yang JC, Rau CS, et al. Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture. PLoS ONE. 2013; 8: e77936.
35. Zhu C, Ren C, Han J, et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer. 2014; 110: 2291-9.
36. Kirschner MB, Kao SC, Edelman JJ, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE. 2011; 6: e24145.
37. Wang X, Sundquist J, Zöller B, et al. Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS ONE. 2014; 9: e86792.
38. Eichelser C, Flesch-Janys D, Chang-Claude J, et al. Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin Chem. 2013; 59: 1489-96.
39. Ji T, Zheng ZG, Wang FM, et al. Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients. Asian Pac J Cancer Prev. 2014; 15: 1739-43.